Skip to content
Comparison

TB-500 vs BPC-157

TB-500 and BPC-157 are commonly compared for systemic versus local healing strategy. TB-500 is usually favored for whole-body recovery and migration signaling, while BPC-157 is often preferred for site-specific tendon/gut repair targeting. This head-to-head analysis focuses on mechanism, trial outcomes, dosing context, evidence quality, regulatory status, and practical decision points for safer YMYL decision-making.

4.3(112 ratings)

Quick Answer

For systemic versus local healing strategy, the better choice depends on your primary endpoint. TB-500 is stronger when the priority is multi-site or diffuse recovery programs. BPC-157 is stronger when the priority is localized tissue-healing priorities. Use evidence grade, dose intensity, access constraints, and tolerability profile to match therapy to the patient profile rather than choosing by hype alone.

Head-to-Head Comparison

CriteriaTB-500BPC-157
Primary mechanismThymosin beta-4 fragment analog enhancing migration/repair pathwaysCytoprotective peptide with angiogenic and tendon-healing signaling
Strongest clinical signalSystemic wound and tissue-repair signals in preclinical modelsStrong preclinical tissue-repair data across tendon, gut, and soft tissue
Typical dosing context2-5 mg weekly divided in 1-2 doses200-500 mcg once or twice daily
AdministrationSubcutaneous or intramuscular injectionSubcutaneous/perilesional or oral forms used in practice
Evidence quality gradePreclinical and translational-heavy, limited controlled human use dataPreclinical-dominant, limited human RCT-quality evidence
Regulatory statusNot FDA-approvedNot FDA-approved
Side-effect burdenGenerally tolerated in reported use; long-term data sparseGenerally well tolerated in reported use; human safety certainty limited
Cost/access contextModerate-to-high depending cycle sizeModerate peptide-market cost
Best candidate profileSystemic recovery protocols covering multiple tissue sitesLocalized tendon/ligament and gut-focused recovery goals
Main limitationEvidence quality lower than approved therapeuticsHuman efficacy evidence remains early-stage
Best use case in this comparisonmulti-site or diffuse recovery programslocalized tissue-healing priorities

When to Choose Each

Choose TB-500

Best for multi-site or diffuse recovery programs.

Choose BPC-157

Best for localized tissue-healing priorities.

Verdict

If the main goal is multi-site or diffuse recovery programs, TB-500 is usually the better first-line choice. If the main goal is localized tissue-healing priorities, BPC-157 is typically the better fit. Reassess outcomes at 8-16 weeks with objective metrics, then adjust only when response, safety, or adherence data justify it. In high-risk populations, physician-guided personalization matters more than any generic ranking.

References

  1. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair (2004) — PubMed
  2. Thymosin β4 promotes angiogenesis and wound healing (2006) — PubMed
  3. The role of thymosin beta-4 in tissue repair and regeneration (2012) — PubMed
  4. Thymosin β4 and its degradation products in wounds (2017) — PubMed

Compare Telehealth Providers

Find the right provider for your peptide therapy needs

Hims & Hers

Most Popular
4.3

Starting at $199/mo

Hims & Hers is a leading telehealth platform offering physician-supervised GLP-1 weight loss programs including compounded semaglutide and tirzepatide. Board-certified providers, async or video consults, and medication shipped to your door.

✓Large, established platform with strong physician network
✓Compounded semaglutide available where branded shortages exist
✓Easy async consult — no video call required
✗Does not offer a wide range of peptides beyond GLP-1s
✗Pricing is on the higher end for GLP-1 programs

Henry Meds

Most Peptides
4.2

Starting at $249/mo

Henry Meds is a telehealth provider specializing in hormone optimization and peptide therapy. Beyond GLP-1 weight loss, Henry Meds offers testosterone replacement therapy, growth hormone peptides, and other advanced hormonal protocols managed by licensed physicians.

✓Broadest peptide therapy menu of any major telehealth provider
✓Growth hormone peptides (sermorelin, ipamorelin, CJC-1295) available
✓Repair peptides including BPC-157 and TB-500
✗Higher starting price due to comprehensive programs
✗More complex onboarding including lab work requirements

Ro Body

Best Value
4.1

Starting at $149/mo

Ro Body is a telehealth weight management program powered by GLP-1 medications. Ro connects patients with licensed providers who prescribe compounded semaglutide or branded GLP-1 therapies depending on eligibility, paired with behavioral coaching.

✓Competitive pricing starting at $149/mo
✓Dedicated health coach included in program
✓Strong clinical protocols with lab-work integration
✗Narrower peptide offering — GLP-1s only
✗Video consult required for initial visit

Calibrate

4.0

Starting at $199/mo

Calibrate is a metabolic health company offering a one-year GLP-1 program built around four pillars: food, sleep, exercise, and emotional health. Calibrate works with insurance to cover medication costs and provides extensive behavioral coaching alongside prescriptions.

✓Insurance navigation support for medication coverage
✓Evidence-based one-year program with structured milestones
✓Four-pillar lifestyle coaching (food, sleep, exercise, emotional health)
✗Annual program commitment required
✗Primarily focused on GLP-1s — no broader peptide therapy

Found

3.9

Starting at $129/mo

Found is a weight management telehealth platform that combines GLP-1 medications with behavioral coaching and a supportive community. Found emphasizes a whole-person approach, pairing pharmacological treatment with lifestyle intervention for sustainable results.

✓One of the more affordable monthly program fees
✓Strong community and peer support features
✓Certified health coaches with regular check-ins
✗Medication billed separately from program fee — total cost can be higher
✗Limited peptide variety beyond standard GLP-1s

Sponsored · We may earn a commission. Learn more · Updated February 2026

Henry MedsMost Peptides

Henry Meds is a telehealth provider specializing in hormone optimization and peptide therapy. Beyond GLP-1 weight loss, Henry Meds offers testosterone replacement therapy, growth hormone peptides, and other advanced hormonal protocols managed by licensed physicians.

From $249/moLearn More →

Sponsored · Affiliate Disclosure

Frequently Asked Questions

Which has stronger evidence for systemic versus local healing strategy — TB-500 or BPC-157?
TB-500 is graded as preclinical and translational-heavy, limited controlled human use data evidence in this context, while BPC-157 is graded as preclinical-dominant, limited human rct-quality evidence. In practice, strength depends on whether you prioritize multi-site or diffuse recovery programs or localized tissue-healing priorities. Favor the option with endpoint data closest to your primary goal, and avoid extrapolating beyond studied populations.
Can TB-500 and BPC-157 be combined or sequenced?
Sometimes, but only with clinician oversight. A common framework is to start with one agent, track objective response for 8-16 weeks, then switch or sequence if outcomes plateau or tolerability is poor. Combination protocols may increase both cost and adverse-effect complexity, so they should be justified by clear endpoint-based rationale.
What should be monitored before and during treatment?
Baseline assessment should include diagnosis confirmation, comorbidity risk, and contraindications. During therapy, monitor target outcomes (symptoms, body composition, labs), adverse effects, and adherence burden. For endocrine/metabolic strategies, periodic glucose, lipids, organ function, and indication-specific labs help keep risk proportional to expected benefit.

Explore next